We are live on ! Find out more
BMY icon

Bristol-Myers Squibb

2,492 hedge funds and large institutions have $100B invested in Bristol-Myers Squibb in 2025 Q1 according to their latest regulatory filings, with 202 funds opening new positions, 960 increasing their positions, 992 reducing their positions, and 168 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital inflows, than outflows

Capital inflows: $7.19B | Capital outflows: $5.12B

20% more first-time investments, than exits

New positions opened: 202 | Existing positions closed: 168

1.44% more ownership

Funds ownership: 78.83% → 80.27% (+1.4%)

2% more call options, than puts

Call options by funds: $1.73B | Put options by funds: $1.7B

0% less funds holding

Funds holding: 2,500 → 2,492 (-8)

3% less repeat investments, than reductions

Existing positions increased: 960 | Existing positions reduced: 992

10% less funds holding in top 10

Funds holding in top 10: 41 → 37 (-4)

Holders
2,492
Holders Change
-8
Holders Change %
-0.32%
% of All Funds
33.26%
Holding in Top 10
37
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-9.76%
% of All Funds
0.49%
New
202
Increased
960
Reduced
992
Closed
168
Calls
$1.73B
Puts
$1.7B
Net Calls
+$27.3M
Net Calls Change
+$18.3M

BMY Hedge Fund Activity: Q1 2025 in Review

2,492 of the 7,492 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q1 2025, worth a combined $100B — up 10% from $90.4B a quarter earlier.

Buyers outnumbered sellers: 202 funds opened new BMY positions and 168 closed out — a net gain of 34 holders — while 960 added to existing stakes and 992 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.2B. The largest seller was Fidelity Investments, cutting an estimated $553M.

  • 2,492 institutional investors held Bristol-Myers Squibb (BMY) as of Q1 2025, down from 2,500 in Q4 2024.
  • Funds reported $100B of Bristol-Myers Squibb stock for Q1 2025, up 10% quarter-over-quarter.
  • 202 funds opened new Bristol-Myers Squibb positions in Q1 2025 and 168 closed out, a net change of +34 holders.
  • The largest Bristol-Myers Squibb buyer in Q1 2025 was Capital International Investors, an estimated $1.2B added.
  • The largest Bristol-Myers Squibb seller in Q1 2025 was Fidelity Investments, an estimated $553M sold.

Based on aggregated 13F filings for Q1 2025.